Whanin, Sandoz Korea to co-market three antidepressants

Published: 2013-01-02 06:57:00

Updated: 2013-01-02 06:57:00

Whanin Pharm and Sandoz Korea on Wednesday announced that the two companies have signed an agreement to co-market three antidepressants (escitalopram, paroxetine and sertraline) from next year in Korea.

Underscoring the important synergy created by this partnership, officials from both compani...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK